HMA stock takes a beating in the market

It's hard to say whether the recent stock-market downturn caused Health Management Associates' stock to lose more than a quarter of its value in five days.

But it didn't help that the company revealed federal investigations into some of its practices in the quarterly results it filed on Aug. 3 with the Securities & Exchange Commission. Among other issues, HMA disclosed that the U.S. Department of Health and Human Resources had sent subpoenas to the company regarding physician referrals, hospital ownership joint ventures and emergency room management.

This is important because joint ventures with physicians and improvements in the emergency rooms at the company's 60 hospitals have been a bright spot for the company. Joint ventures give physicians a stake in improving the performance at hospitals while emergency room efficiencies boost patient revenues.

Indeed, HMA continues to outperform its peers on many levels. It recently reported a 13% jump in revenues and a 25% increase in diluted earnings per share in the second quarter compared with the same quarter a year ago.

HMA's stock closed at $7.68 per share on Wednesday, down roughly 12% from its closing price on Aug. 3.